---
figid: PMC10523227__WJD-14-1349-g001
pmcid: PMC10523227
image_filename: WJD-14-1349-g001.jpg
figure_link: /pmc/articles/PMC10523227/figure/F1/
number: Figure 1
figure_title: ''
caption: 'Optimization of dose of genipin and high glucose in human retinal microvascular
  endothelial cells. A: Chemical structure of genipin; B and C: Cell viability of
  human retinal microvascular endothelial cells (hRMECs) treated with different concentrations
  of glucose and genipin; D: Cell viability of hRMECs treated with 30 mmol/L glucose
  and 0.4 Î¼mol/L genipin for different durations; E-I: RAGE, SCG3, and vascular endothelial
  growth factor protein expression in cells treated with genipin for different durations.
  VEGF: Vascular endothelial growth factor.'
article_title: Genipin relieves diabetic retinopathy by down-regulation of advanced
  glycation end products via the mitochondrial metabolism related signaling pathway.
citation: Ke-Xin Sun, et al. World J Diabetes. 2023 Sep 15;14(9):1349-1368.
year: '2023'

doi: 10.4239/wjd.v14.i9.1349
journal_title: World Journal of Diabetes
journal_nlm_ta: World J Diabetes
publisher_name: Baishideng Publishing Group Inc

keywords:
- Genipin
- Human retinal microvascular endothelial cells
- Angiogenesis
- Vascularization
- Secretogranin III
- Diabetic retinopathy

---
